A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/407 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2264750
The present disclosure relates to the discovery that highly selective butyrylcholinesterase inhibitors can prevent or treat cognitive impairments associated with aging or Alzheimer's disease. A preferred butyrylcholinesterase inhibitor is cymserine.
La présente invention se rapporte à la découverte que des inhibiteurs de butyrylcholinestérase hautement sélectifs peuvent prévenir ou traiter des déficiences cognitives associées au vieillissement ou à la maladie d'Alzheimer. Un inhibiteur préféré de butyrylcholinestérase est la cymsérine.
Brossi Arnold
Greig Nigel H.
Hausman Marvin
Soncrant Timothy T.
Yu Qian-Sheng
Axonyx Inc.
Brossi Arnold
National Institute Of Health
Shapiro Cohen
Soncrant Timothy T.
LandOfFree
Highly selective butyrylcholinesterase inhibitors for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Highly selective butyrylcholinesterase inhibitors for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Highly selective butyrylcholinesterase inhibitors for the... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1459021